PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 21, 2019American Journal of Case Reports20 citationsOpen Access

Treatment of Hypertensive Cardiogenic Edema with Intravenous High-Dose Nitroglycerin in a Patient Presenting with Signs of Respiratory Failure: A Case Report and Review of the Literature

FLFermín López-RiveraHMHéctor R. MartínezCLChristian Castillo Latorre

Structured PICO

Does high-dose intravenous nitroglycerin improve symptoms and prevent the need for mechanical ventilation in a patient with hypertensive cardiogenic pulmonary edema?

P
Population
1 patient (n=1), 63-year-old Hispanic male with a medical history of hypertension, coronary artery disease, heart failure with reduced ejection fraction (LVEF 35%), chronic kidney disease, and diabetes mellitus, presenting with acute severe dyspnea due to hypertensive cardiogenic pulmonary edema.
I
Intervention
100% oxygen supplementation and intravenous high-dose nitroglycerin (started at 30 mcg/min, titrated every 3 minutes by 15 mcg/min up to 120 mcg/min).
O
Outcome
Clinical improvement and avoidance of mechanical ventilation

High-dose intravenous nitroglycerin may be an effective acute treatment for hypertensive cardiogenic pulmonary edema to rapidly improve symptoms and avoid mechanical ventilation.

Abstract

BACKGROUND Pulmonary edema is the accumulation of fluid in the lung secondary to increased hydrostatic pressure. Hypertensive cardiogenic pulmonary edema presents with a sudden onset of severe dyspnea, tachycardia, and tachypnea, and can occur when the systolic blood pressure exceeds 160 mmHg in association with acute decompensated congestive cardiac failure (CCF). A case is presented of hypertensive cardiogenic pulmonary edema treated with high-dose nitroglycerin and includes a review of the literature. CASE REPORT A 63-year-old Hispanic male with a medical history of hypertension, coronary artery disease, heart failure with a reduced ejection fraction of 35%, chronic kidney disease (CKD) and diabetes mellitus, presented as an emergency with acute, severe dyspnea. The patient was initially managed with 100% oxygen supplementation and intravenous (IV) high-dose nitroglycerin (30 mcg/min), which was titrated every 3 minutes, increasing by 15 mcg/min until a dose of 120 mcg/min was reached. After 18 minutes of aggressive therapy, the patient's condition improved and he no longer required mechanical ventilation. CONCLUSIONS Hypertensive cardiogenic pulmonary edema is a challenging clinical condition that should be diagnosed and managed as early as possible, and distinguished from respiratory failure due to other causes. Although hypertensive cardiogenic pulmonary edema is usually managed acutely with high-dose diuretics, this case has highlighted the benefit of high-dose IV nitroglycerin, and review of the literature supports this treatment approach.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

López-Rivera et al. (2019) studied this question.

synapsesocial.com/papers/6a87c70002f504243ce960d9https://doi.org/10.12659/ajcr.913250
Ask AI
Helpful
Bookmark
Share
View Full Paper